Cite
HARVARD Citation
Gu, R. et al. (2021). Evaluation of pretreatment telomere length as a prognostic marker in intermediate‐risk acute myeloid leukemia. International journal of laboratory hematology. pp. 1510-1515. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gu, R. et al. (2021). Evaluation of pretreatment telomere length as a prognostic marker in intermediate‐risk acute myeloid leukemia. International journal of laboratory hematology. pp. 1510-1515. [Online].